Suppr超能文献

A nonsense SCN5A mutation associated with Brugada-type electrocardiogram and intraventricular conduction defects.

作者信息

Samani Kaveh, Ai Tomohiko, Towbin Jeffrey A, Brugada Ramon, Shuraih Mossaab, Xi Yutao, Wu Geru, Cheng Jie, Vatta Matteo

机构信息

Electrophysiology Research Laboratory, Texas Heart Institute/St. Luke's Episcopal Hospital, Houston, Texas.

出版信息

Pacing Clin Electrophysiol. 2009 Sep;32(9):1231-6. doi: 10.1111/j.1540-8159.2009.02470.x.

Abstract

Mutations of SCN5A, gene-encoding alpha-subunit of cardiac sodium channel, can cause mixed phenotypes of Brugada syndrome (BrS) and cardiac conduction diseases (CCD). We have identified a nucleotide change of SCN5A (4178T > G), which results in a nonsense mutation, L1393X, in a 36-year-old Caucasian man who presented with intraventricular conduction delays and BrS-type electrocardiogram change. To study biophysical characteristics of L1393X-SCN5A, electrophysiological and immuno-staining studies were performed using mammalian expression systems. While WT-SCN5A showed significant currents (93.3 +/- 10.6 pA/pF; 1 microg plasmid), L1393X (5 microg) did not generate any significant currents in NIH-3T3 cells. The cells cotransfected with WT (0.5 microg) and L1393X (0.5 microg) showed approximately 50% current amplitudes compared to the WT (1 microg). Voltage dependency of a steady-state activation and inactivation was not affected by the cotransfection of L1393X. Immuno-histochemical stainings demonstrated that L1393X proteins were expressed in the plasma membranes. Our study demonstrated that L1393X-SCN5A does not form functional channel proteins, which might account for the patient's mixed phenotypes of BrS and CCD.

摘要

相似文献

1
A nonsense SCN5A mutation associated with Brugada-type electrocardiogram and intraventricular conduction defects.
Pacing Clin Electrophysiol. 2009 Sep;32(9):1231-6. doi: 10.1111/j.1540-8159.2009.02470.x.
2
A novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness.
Heart Rhythm. 2009 Sep;6(9):1318-26. doi: 10.1016/j.hrthm.2009.05.016. Epub 2009 May 18.
4
Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.
J Interv Card Electrophysiol. 2013 Aug;37(2):131-40. doi: 10.1007/s10840-013-9805-7. Epub 2013 Apr 24.
5
Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.
Heart Rhythm. 2007 Apr;4(4):516-9. doi: 10.1016/j.hrthm.2006.10.028. Epub 2006 Nov 10.
6
Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations.
Cardiovasc Res. 2005 Aug 15;67(3):510-9. doi: 10.1016/j.cardiores.2005.03.024.
7
Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay.
Circulation. 2012 Jan 3;125(1):14-22. doi: 10.1161/CIRCULATIONAHA.111.054007. Epub 2011 Nov 16.
8
Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
Heart Rhythm. 2009 Mar;6(3):341-8. doi: 10.1016/j.hrthm.2008.11.009. Epub 2008 Nov 11.
10
Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.
Pacing Clin Electrophysiol. 2010 Mar;33(3):274-85. doi: 10.1111/j.1540-8159.2009.02642.x. Epub 2009 Dec 16.

引用本文的文献

1
SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias.
Eur Heart J. 2025 May 7;46(18):1747-1762. doi: 10.1093/eurheartj/ehaf053.
2
A Rare Noncoding Enhancer Variant in Contributes to the High Prevalence of Brugada Syndrome in Thailand.
Circulation. 2025 Jan 7;151(1):31-44. doi: 10.1161/CIRCULATIONAHA.124.069041. Epub 2024 Oct 11.
3
The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel!
Front Cardiovasc Med. 2021 Dec 23;8:782596. doi: 10.3389/fcvm.2021.782596. eCollection 2021.
4
Phosphorylation of Lamin A/C at serine 22 modulates Na 1.5 function.
Physiol Rep. 2021 Nov;9(22):e15121. doi: 10.14814/phy2.15121.
5
Brugada Syndrome: Oligogenic or Mendelian Disease?
Int J Mol Sci. 2020 Mar 1;21(5):1687. doi: 10.3390/ijms21051687.
6
SCN5A Nonsense Mutation and NF1 Frameshift Mutation in a Family With Brugada Syndrome and Neurofibromatosis.
Front Genet. 2019 Feb 15;10:50. doi: 10.3389/fgene.2019.00050. eCollection 2019.

本文引用的文献

1
A common SCN5A variant alters the responsiveness of human sodium channels to class I antiarrhythmic agents.
J Cardiovasc Electrophysiol. 2007 Apr;18(4):434-40. doi: 10.1111/j.1540-8167.2007.00777.x. Epub 2007 Jan 10.
2
Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.
J Cardiovasc Electrophysiol. 2006 Mar;17(3):270-5. doi: 10.1111/j.1540-8167.2006.00349.x.
3
High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations.
J Am Coll Cardiol. 2005 Dec 6;46(11):2100-6. doi: 10.1016/j.jacc.2005.08.043. Epub 2005 Nov 4.
6
Brugada syndrome: 1992-2002: a historical perspective.
J Am Coll Cardiol. 2003 May 21;41(10):1665-71. doi: 10.1016/s0735-1097(03)00310-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验